Grace TherapeuticsGRCE
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 34 institutions reported holding Grace Therapeutics Inc. (GRCE) in their 13F filings, up 12 from Q4 2025. 16 opened new positions and 5 sold out. The largest holders were Cerity Partners LLC ($3.9M), Eversept Partners, LP ($3.5M) and Nantahala Capital Management, LLC ($3.4M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Grace Therapeutics Inc.
- CUSIP
- 00439U104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 16 | $6.3M |
| Exits | 5 | $5.5M |
All 13F filers, Q4 2025 → Q1 2026: 1,997,054 shares bought and 2,046,624 shares sold, net −49,570 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Cerity Partners LLC | 0.01% | Add +100.8% | 849,055 | $3.9M |
| Eversept Partners, LP | 0.23% | New | 756,600 | $3.5M |
| Nantahala Capital Management, LLC | 0.21% | Reduce -38.2% | 728,203 | $3.4M |
| Bank of America Corp. | 0.00% | Add +0.0% | 494,723 | $2.3M |
| Vanguard Capital Management LLC | 0.00% | — | 401,656 | $1.9M |
| Renaissance Technologies | 0.00% | Add +87.9% | 243,910 | $1.1M |
| Jane Street Group, LLC | 0.00% | New | 167,097 | $774K |
| Citadel Advisors | 0.00% | Add +133.4% | 98,742 | $457K |
| Marshall Wace, LLP | 0.00% | New | 91,416 | $423K |
| Connective Capital Management, LLC | 0.32% | New | 84,549 | $391K |
| Quadrature Capital Ltd | 0.00% | New | 66,822 | $309K |
| XTX Topco Ltd | 0.01% | Add +108.5% | 63,094 | $292K |
| Birchview Capital, LP | 0.13% | New | 50,000 | $232K |
| Diametric Capital, LP | 0.05% | New | 39,796 | $184K |
| Pale Fire Capital SE | 0.02% | New | 37,762 | $175K |
| UBS Group AG | 0.00% | New | 26,301 | $122K |
| Kestra Private Wealth Services, LLC | 0.00% | New | 13,000 | $60K |
| Prelude Capital Management, LLC | 0.00% | New | 10,074 | $47K |
| Oppenheimer & Co. Inc. | 0.00% | New | 10,000 | $46K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 8,750 | $41K |
| BNP Paribas Financial Markets | 0.00% | Add +1083.3% | 7,100 | $33K |
| Group One Trading LLC | 0.00% | New | 5,000 | $23K |
| Morgan Stanley | 0.00% | Reduce -82.1% | 4,548 | $21K |
| National Bank of Canada | 0.00% | No change | 2,716 | $13K |
| Wells Fargo & Company | 0.00% | New | 1,800 | $8K |
| Royal Bank of Canada | 0.00% | No change | 543 | $3K |
| Arax Advisory Partners | 0.00% | New | 500 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -78.7% | 415 | $2K |
| Activest Wealth Management | 0.00% | No change | 104 | $482 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 82 | $380 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -30.7% | 70 | $324 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 41 | $190 |
| Lanark Financial, Inc. | 0.00% | No change | 2 | $9 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1 | $5 |
"% of holder's portfolio" is GRCE's weight in each manager's 13F, not the share of Grace Therapeutics Inc. the manager owns.